Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 16 Week Randomised, Open-labelled, Four-armed, Treat-to-target, Parallel-group Trial Comparing SIBA D Once Daily, SIBA E Once Daily, SIBA D Monday, Wednesday and Friday and Insulin Glargine Once Daily, All in Combination With Metformin in Subjects With Type 2 Diabetes Failing on OAD Treatment

NCT00611884 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00611884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00611884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 16 Week Randomised, Open-labelled, Four-armed, Treat-to-target, Parallel-group Trial Comparing SIBA D Once Daily, SIBA E Once Daily, SIBA D Monday, Wednesday and Friday and Insulin Glargine Once Daily, All in Combination With Metformin in Subjects With Type 2 Diabetes Failing on OAD Treatment
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
August 31, 2008
Enrollment
245 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2